Anti-PD-1 & PD-L1 Reference Antibody (Reozalimab)

Produktübersicht

• Artikelname: Anti-PD-1 & PD-L1 Reference Antibody (Reozalimab)
• Artikelnummer: SYB-CHBA055
• Hersteller Artikelnummer: CHBA055
• Alternativnummer: SYB-CHBA055-100UG, SYB-CHBA055-1MG
• Hersteller: Sanyou Bio
• Kategorie: Antikörper
• Applikation: ELISA, FA, FACS, Kinetics

Produktbeschreibung

Anti-BAFF & IL-17A Reference Antibody (Tibulizumab) (CHBA001) is expressed from CHO, with a configuration of IgG-scFv. The heavy chain type is huIgG4SP, and the light chain type is Kappa. It has a predicted MW of 201.44 kDa.

Produkteigenschaften

• Konzentration: 1mg/ml
• UniProt: Q15116
• Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
• Reinheit: >95%
• Formulierung: Lyophilize
• Target-Kategorie: PDCD1 / PD-1 / CD279,B7-H1 / PD-L1 / CD274